Product Program year 2025 Source: CMS Open Payments

Gentlecath

Device Continence Care

PDI 30768455153795

Open in the dashboard

General payments

$182,135

5,345 payments

Research payments

$104,636

5 payments

Through program year 2025, $182,135 in general payments and $104,636 in research payments were reported against Gentlecath (Continence Care).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $17,767 433
2024 General $27,967 887
2024 Research $104,636 5
2023 General $59,162 1,786
2022 General $77,239 2,239

Breakdown

Who paid General payments · program years 2022–2025
  1. ConvaTec Inc. $129,916 3,377 payments
  2. 180 Medical, Inc. $52,219 1,968 payments
Top recipients General payments · program year 2025
  1. Erika Orban Nurse Practitioner, Adult Health · Seattle, WA $2,067 12% · 11 payments
  2. Morgan McDowell Nurse Practitioner · Lynchburg, VA $1,668 9% · 11 payments
  3. Memorial Hermann Tirr Teaching hospital · TX $1,000 6% · 1 payment
  4. Ut Southwestern University Hosp Teaching hospital · TX $500 3% · 1 payment
  5. Michael Kennelly Urology · Charlotte, NC $235 1% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Urology $4,497 28% · 123 practitioners
  2. Nurse Practitioner $3,434 21% · 33 practitioners
  3. Physician Assistant $2,653 17% · 53 practitioners
  4. Nurse Practitioner, Adult Health Nurse Practitioner $2,210 14% · 6 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $1,530 10% · 36 practitioners

The top 5 of 26 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Washington $2,393 13% · 7 recipients
  2. Colorado $2,087 12% · 31 recipients
  3. Texas $1,737 10% · 4 recipients
  4. Virginia $1,691 10% · 2 recipients
  5. California $1,561 9% · 41 recipients

The top 5 of 33 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

5,345 general · 5 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record